Key details on Neurocrine Biosciences (Ticker: NBIX)
- CUSIP: 64125C109
- Is NBIX overvalued or undervalued? Run a discounted cash flow (DCF) valuation analysis on NBIX
Who owns Neurocrine Biosciences?
Is NBIX a good stock to own? Find out who bought Neurocrine Biosciences, who sold Neurocrine Biosciences (NBIX) stock, and who holds a large position in Neurocrine Biosciences.
|Fund Name||Number of Shares||Share Valuation||As Of|
|FMR||11.06M||$528.32M||June 30, 2015|
|T. Rowe Price Associates||9.88M||$392.25M||March 31, 2015|
|BVF||5.93M||$50.40M||Dec. 31, 2011|
|OrbiMed Advisors||5.83M||$231.65M||March 31, 2015|
|Vanguard||5.36M||$256.11M||June 30, 2015|
|Perceptive Advisors||3.28M||$156.87M||June 30, 2015|
|BB Biotech AG||3.22M||$153.86M||June 30, 2015|
|BlackRock Fund Advisors||3.18M||$151.65M||June 30, 2015|
|PointState Capital||2.63M||$104.57M||March 31, 2015|
|Westfield Capital Management Company||2.29M||$90.87M||March 31, 2015|
|STATE STREET CORPORATION||2.04M||$97.40M||June 30, 2015|
|BlackRock Institutional Trust Company, N.A.||2.02M||$96.67M||June 30, 2015|
|Visium Asset Management||2.01M||$95.86M||June 30, 2015|
|VHCP Management||1.96M||$26.29M||June 30, 2013|
|Franklin Resources||1.93M||$43.03M||Dec. 31, 2014|
Who sold Neurocrine Biosciences?
|Fund Name||Date Sold||Number of Shares Sold||Share Valuation|
|Wellington Management Company||June 30, 2011||1.93M||$15.56M|